OCULAR MYASTHENIA GRAVIS
Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests Long-Term safety of eye muscle weakness treatment
Disease control Not yet recruitingThis study continues testing rozanolixizumab to see if it's safe and effective for adults with ocular myasthenia gravis over a longer period. The treatment aims to control eye muscle weakness symptoms like drooping eyelids and double vision. Participants must have completed a pre…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
New drug trial targets debilitating eye muscle weakness
Disease control Not yet recruitingThis study aims to test whether an investigational drug called rozanolixizumab can safely reduce eye muscle weakness and improve quality of life for adults with ocular myasthenia gravis. About 120 participants will receive either the drug or a placebo for 43 days while researcher…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC